Patents by Inventor Liangfeng Han

Liangfeng Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HEYL as a therapeutic target and a diagnostic marker for neoplasia and uses therefor
    Patent number: 9540694
    Abstract: The invention generally features compositions and methods that are useful for treating or diagnosing a neoplasia, in particular breast neoplasia. The invention is based in part on the observation that the basic helix loop helix transcription factor HEYL was found to be overexpressed in breast cancer cells. Accordingly, the invention provides therapeutic compositions and methods for altering the levels and expression of HEYL of the invention, thereby treating a neoplasia, as well as compositions and methods for diagnosing a neoplasia.
    Type: Grant
    Filed: May 21, 2007
    Date of Patent: January 10, 2017
    Assignee: The Johns Hopkins University
    Inventors: Saraswati Sukumar, Liangfeng Han
  • Heyl as a Therapeutic Target and a Diagnostic Marker for Neoplasia and Uses Therefor
    Publication number: 20100240574
    Abstract: The invention generally features compositions and methods that are useful for treating or diagnosing a neoplasia, in particular breast neoplasia. The invention is based in part on the observation that the basic helix loop helix transcription factor HEYL was found to be overexpressed in breast cancer cells. Accordingly, the invention provides therapeutic compositions and methods for altering the levels and expression of HEYL of the invention, thereby treating a neoplasia, as well as compositions and methods for diagnosing a neoplasia.
    Type: Application
    Filed: May 21, 2007
    Publication date: September 23, 2010
    Inventors: Saraswati Sukumar, Liangfeng Han